As a key glycolytic enzyme, ENO2 plays a pivotal role in tumor glucose metabolism and has been implicated in enhancing cellular glycolysis and promoting tumorigenesis across various cancers, particularly in the conversion of 2-PG to phosphoenolpyruvate [38, 59]. The gene discussed is HK1; the disease is cancer.